Rare disease drugmaker Alexion to move headquarters to Boston

Alexion Pharmaceuticals said Tuesday that it plans to move its headquarters from New Haven, Connecticut to Boston by mid-2018, becoming the latest big drugmaker to make Massachusetts home. Alexion (Nasdaq: ALXN) said that 400 positions would be located in the new headquarters, with around 450 employees remaining in New Haven. A spokeswoman for the company did not immediately respond to a request for comment on the potential location or size of the new Boston office. Alexion already has an 81,000…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news